Effects of methylenetetrahydrofolate reductase single‐nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities

Chronic Diseases and Translational Medicine - Tập 7 - Trang 169-181 - 2021
Zheng Wang1, Kai Li2, Ling Ouyang3, Hidasa Iko4, Ahmad Javid Safi5, Shan Gao3
1Department of Otorhinolaryngology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China
2Department of Surgical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China
3Department of Obstetrics and Gynecology, The Shengjing Hospital of China Medical University, Shenyang, Liaoning 110001, China
4Japan Shouko Co. Ltd, Nisikujo 3-5-4 Konohanaku Osakashi Osakafu Japan, 554-0012, Japan
5Afghanistan Cancer Foundation, Kart-e-Char, Kabul, Afghanistan

Tóm tắt

AbstractBackgroundRecent studies identifying methylenetetrahydrofolate reductase (MTHFR) polymorphisms associated with breast cancer (BC), ovarian cancer (OC), cervical cancer, and endometrial cancer (EC) have reported conflicting results and been underpowered. To clarify the correlation between MTHFR mutations and these common female malignancies, we conducted a comprehensive meta‐analysis incorporating all eligible publications.MethodsRelevant reports published before January 20, 2020, were retrieved from PubMed, Embase, the Cochrane Library, and the China National Knowledge Infrastructure databases. The odds ratio and 95% confidence interval summaries for the MTHFR 677C/T and 1298A/C polymorphisms in BC, OC, cervical cancer, and EC were estimated.ResultsA total of 171 studies comprising 56,675 cancer cases and 67,559 controls were included. The results showed a markedly elevated risk of cancer susceptibility related to MTHFR 677C/T based on all genetic models. Similarly, we identified a significant correlation between 1298A/C mutation and cancer risk based on overall comparisons among all models, except the heterozygous model. Moreover, subgroup analysis by cancer type revealed a significantly increased risk of BC associated with 677C/T in the five models and of cervical cancer associated with 1298A/C in some models. Based on ethnicity, significant associations were observed between Asian, African, and mixed populations for 677C/T and the Asian population for 1298A/C. With regard to the sample type used for analysis, we detected a positive association between using blood as the DNA source and cancer risk for 677C/T in all genetic models and for 1298A/C in some genetic models. Further stratification of the results revealed that a notably increased risk was associated with the use of polymerase chain reaction‐restriction fragment‐length polymorphism or TaqMan as the genotyping method, as well as with the use of population‐or hospital‐based groups as the controls for 677C/T and 1298A/C, respectively.ConclusionThis meta‐analysis suggests that MTHFR 677C/T and 1298A/C polymorphisms correlate with the risk of common gynecological cancers, with these findings potentially applicable for overall comparisons of related data.

Tài liệu tham khảo

10.3390/cancers12010205 10.1002/jcb.27975 10.3322/caac.21492 10.1016/s1470‐2045(00)00254‐0 10.3322/caac.21590 10.1007/s13277‐012‐0354‐y 10.3389/fonc.2020.01023 10.3892/etm.2019.7771 10.1038/bjc.1995.417 10.1007/s12282‐019‐00961‐8 10.1007/s00404‐016‐4037‐6 10.1007/s003359900838 10.1096/fj.07‐101279 10.1155/2015/167976 10.1038/ng0595‐111 10.1016/s0021‐9150(00)00671‐7 10.3109/09637486.2014.959896 10.1111/tbj.13527 10.2174/13816128113199990564 10.2147/ott.s121472 10.1158/1055‐9965.epi‐09‐0159 10.21010/ajtcam.v13i5.11 Wang Y., 2015, MTHFR gene A1298C polymorphisms are associated with breast cancer risk among Chinese population: evidence based on an updated cumulative meta‐analysis, Int J Clin Exp Med, 8, 20146 10.1371/journal.pone.0071290 Vaĭner A.S., 2010, Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia, Mol Biol, 44, 816 10.1007/s11033‐012‐1852‐0 Paynter R.A., 2004, No association between MTHFR 677 C‐>T or 1298 A‐>C polymorphisms and endometrial cancer risk, Canc Epidemiol Biomarkers Prev, 13, 1088, 10.1158/1055-9965.1088.13.6 10.1016/0197‐2456(86)90046‐2 Mantel N., 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719 10.2307/2533446 10.1136/bmj.315.7109.629 10.1007/s13277‐015‐3648‐z 10.31557/apjcp.2019.20.9.2569 10.1007/s00438‐015‐1082‐y 10.1186/1746‐1596‐7‐171 10.1007/s12687‐016‐0277‐1 10.1093/jnci/djj440 10.1111/j.1399‐0004.2006.00605.x 10.1007/s11033‐012‐2056‐3 10.1016/j.tjog.2015.08.005 10.1016/j.mehy.2013.01.025 10.1371/journal.pone.0052381 10.1016/j.ymgme.2006.02.011 10.1006/mgme.1998.2714 10.4103/0028‐3886.24703 10.1097/MCO.0b013e32831cec62 10.3892/mmr.2013.1589 10.1002/ijc.29210 10.1007/s10549‐010‐0783‐5 10.1159/000070424 10.3892/ijmm.8.5.573 10.1016/j.meegid.2016.10.012 10.1016/j.ygyno.2005.10.019 10.1038/s41598‐018‐25726‐9 10.1016/j.prp.2012.07.001